• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BE人结肠癌细胞对顺二氯二氨铂(II)获得性耐药的特征分析

Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.

作者信息

Fram R J, Woda B A, Wilson J M, Robichaud N

机构信息

Department of Medicine, University of Massachusetts Medical School, Worcester 01655.

出版信息

Cancer Res. 1990 Jan 1;50(1):72-7.

PMID:2293559
Abstract

To study mechanisms underlying resistance to cis-diamminedichloroplatinum (II) (cis-DDP) we have induced resistance to this agent in BE human colon carcinoma cells. A 5-fold increase in the IC50 of resistant compared to sensitive cells was noted as analyzed by the inhibition of cellular growth. Up to a 4-fold reduction in interstrand cross-link formation by cis-DDP in resistant compared to sensitive cells was present as measured by alkaline elution. No significant differences were detectable either in the extent of DNA platination as analyzed by atomic absorption spectroscopy or in the induction of cis-DDP DNA adducts as evaluated by an enzyme-linked immunosorbent assay employing antiserum that detects intrastrand cross-links formed by cis-DDP. Further, no differences in the kinetics of excision of DNA interstrand cross-links, cis-DDP DNA adducts, or total platinum in DNA were present. Levels of glutathione, however, were increased about threefold in resistant compared to sensitive cells. Loss of resistance was associated with increased interstrand cross-link formation and declines in glutathione levels. Our results are consistent with a critical role of glutathione in preventing platinum monoadduct rearrangements resulting in lower levels of interstrand cross-links and resistance to cis-DDP in resistant BE cells.

摘要

为了研究顺二氯二氨铂(II)(顺铂)耐药的潜在机制,我们在BE人结肠癌细胞中诱导了对该药物的耐药性。通过细胞生长抑制分析发现,与敏感细胞相比,耐药细胞的半数抑制浓度(IC50)增加了5倍。通过碱性洗脱法测定,与敏感细胞相比,耐药细胞中顺铂诱导的链间交联形成减少了4倍。通过原子吸收光谱分析的DNA铂化程度,或通过使用检测顺铂形成的链内交联的抗血清的酶联免疫吸附测定评估的顺铂DNA加合物诱导情况,均未检测到显著差异。此外,DNA链间交联、顺铂DNA加合物或DNA中总铂的切除动力学也没有差异。然而,与敏感细胞相比,耐药细胞中的谷胱甘肽水平增加了约三倍。耐药性的丧失与链间交联形成增加和谷胱甘肽水平下降有关。我们的结果表明,谷胱甘肽在防止铂单加合物重排中起关键作用,从而导致耐药BE细胞中链间交联水平降低和顺铂耐药。

相似文献

1
Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.BE人结肠癌细胞对顺二氯二氨铂(II)获得性耐药的特征分析
Cancer Res. 1990 Jan 1;50(1):72-7.
2
Role of carrier ligand in platinum resistance of human carcinoma cell lines.载体配体在人癌细胞系铂耐药中的作用。
Cancer Res. 1993 Feb 15;53(4):799-805.
3
Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.顺铂敏感性与体外两种人卵巢癌细胞系中铂-DNA加合物形成及清除之间的异常关系。
Cancer Res. 1991 Sep 1;51(17):4557-64.
4
Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.DNA的淬灭:铂(II)单加合物作为L1210细胞对顺二氨二氯铂(II)耐药的一种可能机制
Cancer Res. 1983 Aug;43(8):3609-13.
5
Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.一株体外获得顺二氯二氨铂耐药性的人小细胞肺癌细胞系的特性研究
Cancer Res. 1988 Dec 1;48(23):6803-7.
6
Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.拓扑异构酶II抑制作用以及在人胶质母细胞瘤细胞中,亚硝基脲和顺铂诱导的DNA链间交联的形成与修复动力学改变和细胞毒性
Cancer Res. 1993 Dec 1;53(23):5663-8.
7
Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).在对顺二氯二氨铂(II)耐药的人卵巢癌细胞系中,与DNA结合的铂的清除增加。
Cancer Res. 1990 Mar 15;50(6):1863-6.
8
Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.通过氨基/胺铂(IV)二羧酸盐利用两对人卵巢癌细胞系对获得性顺二氯二氨铂(II)耐药性进行与机制相关的规避
Cancer Res. 1992 Jul 15;52(14):3857-64.
9
Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.顺二氯二氨合铂(II)对六种哺乳动物细胞系的细胞杀伤作用与顺二氯二氨合铂(II)-DNA抗血清结合之间的相关性。
Cancer Res. 1990 Jun 15;50(12):3556-61.
10
New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.新型铂、钛和钌配合物对大鼠卵巢肿瘤细胞DNA损伤的不同模式
Cancer Res. 1991 Jun 1;51(11):2943-8.

引用本文的文献

1
The interaction of DNA-targeted platinum phenanthridinium complexes with DNA.靶向DNA的铂菲啶鎓配合物与DNA的相互作用。
Nucleic Acids Res. 1998 Sep 1;26(17):3933-9. doi: 10.1093/nar/26.17.3933.
2
Correlation of the in vitro cytotoxicity of ethyldeshydroxysparsomycin and cisplatin with the in vivo antitumour activity in murine L1210 leukaemia and two resistant L1210 subclones.乙基去羟基 sparsomycin和顺铂的体外细胞毒性与对小鼠L1210白血病及两个耐药L1210亚克隆的体内抗肿瘤活性的相关性。
Cancer Chemother Pharmacol. 1993;31(4):289-94. doi: 10.1007/BF00685673.
3
Inhibition of cisplatin-mediated DNA damage in vitro by ribonucleotides.
核糖核苷酸在体外对顺铂介导的DNA损伤的抑制作用。
Jpn J Cancer Res. 1993 Apr;84(4):462-7. doi: 10.1111/j.1349-7006.1993.tb00159.x.
4
The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).非小细胞肺癌细胞系(PC-14)及其顺铂耐药亚系(PC-14/CDDP)中铂衍生物细胞摄取差异的机制。
Jpn J Cancer Res. 1993 Jan;84(1):83-92. doi: 10.1111/j.1349-7006.1993.tb02788.x.
5
In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.对顺铂具有内在和获得性耐药性的人宫颈鳞状细胞癌细胞系的体外铂类药物化学敏感性
Br J Cancer. 1993 Aug;68(2):240-50. doi: 10.1038/bjc.1993.322.
6
Human cell lines as models for multidrug resistance in solid tumours.人类细胞系作为实体瘤多药耐药性的模型。
Cytotechnology. 1993;12(1-3):231-56. doi: 10.1007/BF00744666.
7
Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.人卵巢癌细胞中铂类抗癌药物获得性耐药的建立与表征
Jpn J Cancer Res. 1995 Jan;86(1):88-94. doi: 10.1111/j.1349-7006.1995.tb02992.x.
8
Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.人类生殖细胞肿瘤和结肠癌细胞系对顺铂敏感性差异的细胞基础。
Br J Cancer. 1995 Apr;71(4):684-90. doi: 10.1038/bjc.1995.135.
9
Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.在具有细胞内谷胱甘肽和谷胱甘肽-S-转移酶活性升高的美法仑耐药性乳腺癌细胞中氮芥与DNA的相互作用。
Cancer Chemother Pharmacol. 1992;30(5):341-7. doi: 10.1007/BF00689960.
10
Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.顺二氨二氯铂(II)耐药人非小细胞肺癌细胞系对氟尿嘧啶侧支敏感性的机制
Br J Cancer. 1992 Jun;65(6):857-64. doi: 10.1038/bjc.1992.181.